Perfluorooctanoic acid induces migration and invasion and inhibits apoptosis through the PI3K/AKT signaling pathway in human rhabdomyosarcoma cells

Zhang,Qian; Wang,Jianan; Chen,Chen; Kong,Yi; Yan,Hong; Duan,Jinyan; Wang,Chi; Sha,Yingjiao; Wen,Xinyu; Wang,Chengbin

doi:10.3892/or.2019.7265

Perfluorooctanoic acid induces migration and invasion and inhibits apoptosis through the PI3K/AKT signaling pathway in human rhabdomyosarcoma cells

Authors:
- Qian Zhang
- Jianan Wang
- Chen Chen
- Yi Kong
- Hong Yan
- Jinyan Duan
- Chi Wang
- Yingjiao Sha
- Xinyu Wen
- Chengbin Wang
View Affiliations

Affiliations: Chinese PLA Department of Clinical Laboratory Medicine and Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing 100853, P.R. China
Published online on: August 6, 2019 https://doi.org/10.3892/or.2019.7265
Pages: 1558-1568

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effects of perfluorooctanoic acid (PFOA) on tumor cell migration, invasion and apoptosis by activation of the PI3K/AKT signaling pathway in human rhabdomyosarcoma (RMS). PFOA is a persistent, synthetic organic environment pollutant, which has been previously associated with multiple diseases, including cancer. The present study aimed to confirm whether PFOA can elicit cell growth in the RD subline of RBS. RD cells were treated with different concentrations of PFOA. Cell proliferation was evaluated using Cell Counting Kit‑8 and cell cycle assays. Cell migration and invasion were determined using wound healing and Transwell assays. Apoptotic rates were estimated by Annexin V‑FITC/propidium iodide staining. The expression levels of vimentin, serum/glucocorticoid‑regulated kinase 1 (SGK1), cyclin E2, cyclin dependent kinase (CDK)2, p53, p21, p27, phosphatidylinositol‑3 kinase (PI3K) and protein kinase B (AKT), and apoptosis‑associated genes and proteins (including Bcl‑2 and Bax) were detected by reverse transcription‑PCR and western blot analyses. The results showed that PFOA significantly promoted RD cell proliferation, migration and invasion and significantly inhibited RD cell apoptosis. Exposure to PFOA also induced the expression of vimentin, SGK1, cyclin E2, CDK2, AKT, PI3K and Bcl‑2, but suppressed the expression of Bax in the RD cells. The treatment of RD cells with BEZ235, a PI3K inhibitor, antagonized the effects of PFOA on metastatic formation and apoptosis. The results obtained show that the PI3K/AKT signaling pathway is implicated in mediating the pro‑neoplastic effects of PFOA. The data suggests that PFOA is a carcinogen capable of promoting RD cell migration and invasion and inhibiting apoptosis through the PI3K/AKT signaling pathway.

View Figures

View References

1	Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB and Steenland K: Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect. 118:222–228. 2010. View Article : Google Scholar : PubMed/NCBI
2	Shin HM, Vieira VM, Ryan PB, Steenland K and Bartell SM: Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 health project. Environ Health Perspect. 119:1760–1765. 2011. View Article : Google Scholar : PubMed/NCBI
3	Barry V, Winquist A and Steenland K: Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect. 121:1313–1318. 2013. View Article : Google Scholar : PubMed/NCBI
4	Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A and Seed J: Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol Sci. 99:366–394. 2007. View Article : Google Scholar : PubMed/NCBI
5	Pierozan P, Jerneren F and Karlsson O: Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells. Arch Toxicol. 92:1729–1739. 2018. View Article : Google Scholar : PubMed/NCBI
6	Wielsøe M, Kern P and Bonefeld-Jørgensen EC: Serum levels of environmental pollutants is a risk factor for breast cancer in Inuit: a case control study. Environ Health. 16:562017. View Article : Google Scholar : PubMed/NCBI
7	Cha YH, Yook JI, Kim HS and Kim NH: Catabolic metabolism during cancer EMT. Arch Pharm Res. 38:313–320. 2015. View Article : Google Scholar : PubMed/NCBI
8	Natarajan J, Chandrashekar C and Radhakrishnan R: Critical biomarkers of epithelial-mesenchymal transition in the head and neck cancers. J Cancer Res Ther. 10:512–518. 2014.PubMed/NCBI
9	Myong NH: Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol. 46:341–348. 2012. View Article : Google Scholar : PubMed/NCBI
10	Liu W, Wang X, Wang Y, Dai Y, Xie Y, Ping Y, Yin B, Yu P, Liu Z, Duan X, et al: SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 37:732018. View Article : Google Scholar : PubMed/NCBI
11	Jeanes A, Gottardi CJ and Yap AS: Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
12	Satelli A and Li S: Vimentin as a potential molecular target in cancer therapy or Vimentin, an overview and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
13	Ibrahim U, Saqib A, Mohammad F, Ding J, Salman B, Collado FK and Dhar M: Embryonal rhabdomyosarcoma of the cervix: A rare disease at an uncommon age. Cureus. 9:e18642017.PubMed/NCBI
14	Mummery CL, van den Brink CE and de Laat SW: Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent. Dev Biol. 121:10–19. 1987. View Article : Google Scholar : PubMed/NCBI
15	Filipczyk AA, Laslett AL, Mummery C and Pera MF: Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res. 1:45–60. 2007. View Article : Google Scholar : PubMed/NCBI
16	Santamaria D and Ortega S: Cyclins and CDKS in development and cancer: Lessons from genetically modified mice. Front Biosci. 11:1164–1188. 2006. View Article : Google Scholar : PubMed/NCBI
17	Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D and Dalton S: Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene. 21:8320–8333. 2002. View Article : Google Scholar : PubMed/NCBI
18	Courtney KD, Corcoran RB and Engelman JA: The PI3K pathway as drug target in human cancer. J Clin Oncol. 28:1075–1083. 2010. View Article : Google Scholar : PubMed/NCBI
19	Fruman DA and Rommel C: PI3K and cancer: Lessons, challenges and opportunities. Nat Rev Drug Discov. 13:140–156. 2014. View Article : Google Scholar : PubMed/NCBI
20	Meng X, Dong X, Wang W, Yang L, Zhang X, Li Y, Chen T, Ma H, Qi D and Su J: Natural borneol enhances paclitaxel-induced apoptosis of ESCC cells by inactivation of the PI3K/AKT. J Food Sci. 83:1436–1443. 2018. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Yan S, Wang J, Zhang W and Dai J: Circulating microRNA profiles altered in mice after 28 d exposure to perfluorooctanoic acid. Toxicol Lett. 224:24–31. 2014. View Article : Google Scholar : PubMed/NCBI
23	Yang F, Qian XJ, Qin W, Deng R, Wu XQ, Qin J, Feng GK and Zhu XF: Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma. PLoS One. 8:e598792013. View Article : Google Scholar : PubMed/NCBI
24	Ma Z, Liu X, Li F, Wang Y, Xu Y, Zhang M and Zhang X, Ying X and Zhang X: Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/mTOR signaling. Oncotarget. 7:66558–66568. 2016. View Article : Google Scholar : PubMed/NCBI
25	Blum JM, Añó L, Li Z, Van Mater D, Bennett BD, Sachdeva M, Lagutina I, Zhang M, Mito JK, Dodd LG, et al: Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. Cell Rep. 5:933–940. 2013. View Article : Google Scholar : PubMed/NCBI
26	Pierozan P and Karlsson O: PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells. Arch Toxicol. 92:705–716. 2018. View Article : Google Scholar : PubMed/NCBI
27	Tsuda S: Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). J Toxicol Sci 41 (Special). SP27–SP36. 2016. View Article : Google Scholar
28	Hwang HC and Clurman BE: Cyclin E in normal and neoplastic cell cycles. Oncogene. 24:2776–2786. 2005. View Article : Google Scholar : PubMed/NCBI
29	Marampon F, Ciccarelli C and Zani BM: Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Mol Cancer. 5:312006. View Article : Google Scholar : PubMed/NCBI
30	Le Page C, Huntsman DG, Provencher DM and Mes-Masson AM: Predictive and prognostic protein biomarkers in epithelial ovarian cancer: Recommendation for future studies. Cancers (Basel). 2:913–954. 2010. View Article : Google Scholar : PubMed/NCBI
31	Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF and Henshall SM: Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res. 10:5168–5177. 2004. View Article : Google Scholar : PubMed/NCBI
32	Milde-Langosch K and Riethdorf S: Role of cell-cycle regulatory proteins in gynecological cancer. J Cell Physiol. 196:224–244. 2003. View Article : Google Scholar : PubMed/NCBI
33	He G, Kuang J, Huang Z, Koomen J, Kobayashi R, Khokhar AR and Siddik ZH: Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21. Br J Cancer. 95:1514–1524. 2006. View Article : Google Scholar : PubMed/NCBI
34	Qin Y, Guo H, Tang B and Yang SM: The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review). Int J Oncol. 45:525–531. 2014. View Article : Google Scholar : PubMed/NCBI
35	Satelli A and Li S: Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
36	Yao Y, Jiang Q, Jiang L, Wu J, Zhang Q, Wang J, Feng H and Zang P: Lnc-SGK1 induced by Helicobacter pylori infection and highsalt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling. Oncotarget. 7:20549–20560. 2016. View Article : Google Scholar : PubMed/NCBI
37	Szmulewitz RZ, Chung E, Al-Ahmadie H, Daniel S, Kocherginsky M, Razmaria A, Zagaja GP, Brendler CB, Stadler WM and Conzen SD: Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers. Prostate. 72:157–164. 2012. View Article : Google Scholar : PubMed/NCBI
38	Jo A, Yun HJ, Kim JY, Lim SC, Choi HJ, Kang BS, Choi BY and Choi HS: Prolyl isomerase PIN1 negatively regulates SGK1 stability to mediate tamoxifen resistance in breast cancer cells. Anticancer Res. 35:785–794. 2015.PubMed/NCBI
39	Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T and Evers BM: mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71:3246–3256. 2011. View Article : Google Scholar : PubMed/NCBI
40	Hassan M, Watari H, AbuAlmaaty A, Ohba Y and Sakuragi N: Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
41	Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC and Fornace AJ Jr: An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60:6101–6110. 2000.PubMed/NCBI
42	Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM: p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 11:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
43	Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene. 22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
44	Cantley LC and Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA. 96:4240–4245. 1999. View Article : Google Scholar : PubMed/NCBI
45	Blanco-Aparicio C, Renner O, Leal JF and Carnero A: PTEN, more than the AKT pathway. Carcinogenesis. 28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI